The Role of Temozolomide-Irinotecan in Doxorubicin- Resistant Cell Lines of Recurrent Ewing’s Sarcoma, in A Patient Derived Orthotopic Xenograft (PDOX) with EWS-ERG Fusion and CDKN2A Loss: What Impact the Combination has in Real Life Practice?
Keyword(s):
Keyword(s):
2017 ◽
Vol 119
(1)
◽
pp. 967-972
◽
Keyword(s):
2020 ◽
Vol 21
(12)
◽
pp. 4460
◽
Keyword(s):
1995 ◽
Vol 13
(9)
◽
pp. 2336-2341
◽
2007 ◽
Vol 103
(4)
◽
pp. 1344-1354
◽
Keyword(s):
2004 ◽
Vol 64
(15)
◽
pp. 5415-5424
◽
Keyword(s):